Literature DB >> 18299445

Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy.

Lea Sorensen1, Philip J Siddall, Michael I Trenell, Dennis K Yue.   

Abstract

OBJECTIVE: Magnetic resonance spectroscopy (MRS) (specifically, (1)H-MRS) has been used to show changes in the brain following peripheral nerve injury in subjects without diabetes. This study used (1)H-MRS to examine the brain in subjects with or without painful diabetic neuropathy. RESEARCH DESIGN AND METHODS: Twenty-six diabetic subjects (12 with and 14 without chronic neuropathic pain) were compared, with 18 subjects without diabetes and pain. The left thalamus, anterior cingulate cortex (ACC), and dorsolateral prefrontal cortex (DLPFC) were assessed using (1)H-MRS.
RESULTS: In the DLPFC, diabetic subjects had a decrease in N-acetyl aspartate (NAA) and creatine relative to the control group. In the thalamus, there was a reduction of NAA in the diabetic group with pain compared with that in patients with diabetes and no pain.
CONCLUSION: Subjects with diabetes have metabolite differences in the brain compared with control subjects. Subjects with painful neuropathy showed reduced NAA in the thalamus, which may explain the genesis of pain in some cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299445     DOI: 10.2337/dc07-2088

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

Review 1.  Pain imaging in health and disease--how far have we come?

Authors:  Petra Schweinhardt; M Catherine Bushnell
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 2.  How close are we in utilizing functional neuroimaging in routine clinical diagnosis of neuropathic pain?

Authors:  David Borsook; Lino Becerra
Journal:  Curr Pain Headache Rep       Date:  2011-06

3.  Decreased response inhibition in middle-aged male patients with type 2 diabetes.

Authors:  Kaya T Ishizawa; Hiroaki Kumano; Atsushi Sato; Hiroshi Sakura; Yasuhiko Iwamoto
Journal:  Biopsychosoc Med       Date:  2010-02-11

Review 4.  Neuropathic pain in diabetes--evidence for a central mechanism.

Authors:  Tanya Z Fischer; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 5.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

6.  Subacute Pain after Traumatic Brain Injury Is Associated with Lower Insular N-Acetylaspartate Concentrations.

Authors:  Eva Widerström-Noga; Varan Govind; James P Adcock; Bonnie E Levin; Andrew A Maudsley
Journal:  J Neurotrauma       Date:  2016-01-15       Impact factor: 5.269

Review 7.  Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Philip L De Jager
Journal:  Biochem Pharmacol       Date:  2014-02-06       Impact factor: 5.858

Review 8.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

Review 9.  Challenges of functional imaging research of pain in children.

Authors:  Simona Sava; Alyssa A Lebel; David S Leslie; Athena Drosos; Charles Berde; Lino Becerra; David Borsook
Journal:  Mol Pain       Date:  2009-06-16       Impact factor: 3.395

10.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain.

Authors:  Franco Cauda; Katiuscia Sacco; Federico D'Agata; Sergio Duca; Dario Cocito; Giuliano Geminiani; Filippo Migliorati; Gianluca Isoardo
Journal:  BMC Neurosci       Date:  2009-11-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.